Acute Monoarthritis in a Patient on Apixaban

Aspirate now - do not wait for apixaban to be held.

Reasoning:

• The differential includes septic arthritis, which destroys cartilage within days. A delay of 24–48 hours to reverse anticoagulation is a delay in the one diagnosis you cannot afford to miss. His risk profile is high: recent intra-articular injection, fever, an inflammatory synovial picture, and inability to bear weight.
• Therapeutic anticoagulation is not an absolute contraindication to arthrocentesis. It is a superficial, compressible, low-bleeding-risk procedure in a joint with no overlying cellulitis, and it can be done with a small-gauge needle (18–20 G), a single pass, and firm pressure for several minutes afterward.
• Check that platelets are adequate (186,000/µL is fine) and that there is no other bleeding diathesis; coagulation studies are normal.
• If the proceduralist insists on modification, the maximum concession is to skip one dose timed around the procedure - never to delay by days, and never to reverse with a reversal agent for a knee aspiration.

His prior gout and prior steroid injection are exactly the red herrings the scenario is built on: both raise the probability of crystal disease and both raise the probability of iatrogenic infection. Only the fluid distinguishes them.

Treat as septic arthritis until proven otherwise.

Key points:

• Crystals do not exclude infection. Coexisting crystal disease and septic arthritis occurs in a meaningful minority of cases (classically quoted around 5%), and a joint that has been recently injected is a plausible inoculation event.
• A negative Gram stain is unhelpful for exclusion - it is positive in only roughly half of culture-proven septic arthritis. Send cell count and differential, Gram stain, crystal analysis, and bacterial culture; also send blood cultures before antibiotics.
• A white cell count above 50,000/µL is classic for sepsis, but septic joints frequently fall in the 25,000–50,000 range, overlapping with gout. The cell count alone cannot separate them.

Action:

• Start empiric intravenous antibiotics after the aspiration (do not delay aspiration to give antibiotics; do not delay antibiotics for hours awaiting aspiration in a stable patient if aspiration is imminent).
• Admit for intravenous therapy, serial examination, and joint drainage if the effusion reaccumulates.
• Reassess at 48–72 hours: if cultures remain negative and he has improved on gout therapy, the diagnosis can be revised to crystal flare and antibiotics narrowed or stopped.
• Do not repeat the intra-articular steroid injection.

Organism to cover: Staphylococcus aureus, including MRSA. The route of inoculation here is a percutaneous intra-articular injection three weeks earlier, which most often introduces skin flora - staphylococci and streptococci. Gram-negative and anaerobic coverage is reserved for unusual exposures, immunosuppression, or bowel surgery.

Regimen:

• Vancomycin 15–20 mg/kg IV loading dose, then dosed by level (AUC-guided), which covers MRSA and streptococci. In CKD stage 3b the maintenance interval must be extended and levels followed closely; involve pharmacy.
• Alternative or addition: cefazolin 2 g IV every 8 hours, renally adjusted, if MRSA is not suspected.
• Do not rely on oral antibiotics for septic arthritis; joint penetration and bactericidal effect are inadequate for initial therapy.

Practical adjustments for his kidneys:

• Avoid aminoglycosides and avoid vancomycin combined with piperacillin-tazobactam unless a strong indication exists, given the nephrotoxicity signal.
• Avoid NSAIDs for pain - they are especially hazardous with his CKD and with therapeutic anticoagulation.
• Repeat creatinine daily; watch for vancomycin accumulation.
• Orthopedic surgery should be involved early for consideration of serial aspiration or arthroscopy if he does not improve within 48–72 hours.